A placebo-controlled, double-blind study evaluating the effect of orally administered polyunsaturated fatty acids on the oclacitinib dose for atopic dogs
CONCLUSION: Oral supplementation of PUFA allowed dose reduction of oclacitinib and improved PVAS, QoL, QoC and GA. The use of PUFA is recommended and was safe in the atopic study dogs receiving oclacitinib.PMID:38465482 | DOI:10.1111/vde.13246
Source: Veterinary Dermatology - Category: Veterinary Research Authors: Laura Sch äfer Nina Thom Source Type: research
More News: Dermatitis | Dermatology | Fish | Fish Oil | Prednisolone | Skin | Study | Veterinary Research